1. Home
  2. TANH vs INM Comparison

TANH vs INM Comparison

Compare TANH & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tantech Holdings Ltd.

TANH

Tantech Holdings Ltd.

HOLD

Current Price

$1.02

Market Cap

3.2M

Sector

N/A

ML Signal

HOLD

Logo InMed Pharmaceuticals Inc.

INM

InMed Pharmaceuticals Inc.

HOLD

Current Price

$1.43

Market Cap

3.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TANH
INM
Founded
2001
1981
Country
China
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2M
3.7M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
TANH
INM
Price
$1.02
$1.43
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
40.6K
893.9K
Earning Date
01-02-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$42,940,136.00
$4,798,116.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.93
$1.13
52 Week High
$10.77
$8.27

Technical Indicators

Market Signals
Indicator
TANH
INM
Relative Strength Index (RSI) 34.80 46.19
Support Level $1.02 $1.28
Resistance Level $1.13 $1.52
Average True Range (ATR) 0.07 0.11
MACD 0.01 0.03
Stochastic Oscillator 25.47 75.00

Price Performance

Historical Comparison
TANH
INM

About TANH Tantech Holdings Ltd.

Tantech Holdings Ltd manufactures bamboo charcoal-based products. The company, through its subsidiaries, is engaged in the production and distribution of household products along with a trading business, which involves the export of charcoal products. It also manufactures electric double-layer capacitors carbon materials and low-emission barbecue charcoal. Its product portfolio includes air purifiers and humidifiers, underfloor humidity control, pillows and mattresses, wardrobe deodorizers, mousepads, and wrist mats, refrigerator deodorant, and charcoal toilet cleaner disks. The company has two reportable segments: the Consumer Product segment, and the Electric Vehicle (EV) segment.

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.

Share on Social Networks: